Biomarker Testing in Non-Small Cell Lung Cancer A Clinician's Perspective

被引：5
|
作者：
Bernicker, Eric [1 ]
机构：
[1] Houston Methodist Hosp, Thorac Med Oncol, Houston, TX 77030 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2015年 / 139卷 / 04期
关键词：
PHASE-II TRIAL; 1ST-LINE TREATMENT; OPEN-LABEL; EGFR; CHEMOTHERAPY; MUTATIONS; ERLOTINIB; CARBOPLATIN; COMBINATION; PACLITAXEL;
D O I：
10.5858/arpa.2014-0085-ED
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [31] Biomarker Testing and Associated Treatment patterns in Advanced Non-Small Cell Lung Cancer in the US
    Last, M.
    Burlison, H.
    Chandrasekar, S.
    Wong, C. Hooi
    Bailey, H.
    Forshaw, C.
    Foley, G.
    Duncan, K.
    Krulewicz, S.
    Wiltshire, R.
    Thomaidou, D.
    Iadeluca, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E26 - E26
  • [32] Predictive biomarker testing rates in patients with metastatic non-small cell lung cancer in The Netherlands
    de Jager, V.
    Garcia, B. N. Cajiao
    Kuijpers, C. C.
    de Bock, G. H.
    Maas, W. J.
    Timens, W.
    van Kempen, L. C.
    van der Wekken, A. J.
    Schuuring, E.
    Willems, S. M.
    VIRCHOWS ARCHIV, 2024, 485 : S139 - S140
  • [33] Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable
    Kim, Edward S.
    Roy, Upal Basu
    Ersek, Jennifer L.
    King, Jennifer
    Smith, Robert A.
    Martin, Nicole
    Martins, Renato
    Moore, Amy
    Silvestri, Gerard A.
    Jett, James
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 338 - 342
  • [34] Impact of lung biomarker testing on out-of-pocket costs for metastatic non-small cell lung cancer
    Gharzai, Laila A.
    Bell, Sarah
    Gupta, Divya Myadam
    Carlos, Ruth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Advancements in Non-Small Cell Lung Cancer Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
    Jager, Vincent D. de
    Timens, Wim
    Bayle, Arnaud
    Botling, Johan
    Brcic, Luka
    Buettner, Reinhard
    Fernandes, Maria Gabriela O.
    Havel, Libor
    Hochmair, Maximilian J.
    Hofman, Paul
    Janssens, Annelies
    Johansson, Mikael
    van Kempen, Leon
    Kern, Izidor
    Lopez-Rios, Fernando
    Luchtenborg, Margreet
    Machado, Jose Carlos
    Mohorcic, Katja
    Paz-Ares, Luis
    Popat, Sanjay
    Ryska, Ales
    Taniere, Phillipe
    Wolf, Juergen
    Schuuring, Ed
    van der Wekkenz, Anthonie J.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 38
  • [36] Clinician Perspective on Molecular Profiling of Non-Small-Cell Lung Cancer
    Decatris, Marios P.
    Farrugia, David
    O'Byrne, Kenneth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (08) : 884 - +
  • [37] Clinical perspective of afatinib in non-small cell lung cancer
    Chen, Xiaofeng
    Zhu, Quan
    Zhu, Lingjun
    Pei, Dong
    Liu, Yiqian
    Yin, Yongmei
    Schuler, Martin
    Shu, Yongqian
    LUNG CANCER, 2013, 81 (02) : 155 - 161
  • [38] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
  • [39] Molecular Diagnostic Testing in Non-Small Cell Lung Cancer
    Naidoo, Jarushka
    Drilon, Alexander
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (04) : 4 - 11
  • [40] Biomarker Testing in Non-Small Cell Lung Carcinoma: Performance and Patient Outcomes
    Fadel, Saleh
    Chirip, Venus
    Wheatley-Price, Paul
    Reaume, Neil
    Lo, Bryan
    Chang, Nina
    Sekhon, Harmanjatinder
    Gomes, Marcio
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1103 - 1104
12345